Earnings4572Carna Biosciences,Inc.
Carna Biosciences Inc. Reports Q2 Revenue of 400 million, Up 60%
TOKYO, Aug 06 (Pulse News Wire) – Carna Biosciences, Inc. (4572.T) reported consolidated results for Q2 FY2026 (ending December 2026).
Revenue was ¥400 million (+59.8% YoY). operating profit was -¥954 million.
Net profit was -¥1,039 million. Total assets stood at ¥1.2 billion with an equity ratio of 25.1%.
The full-year forecast for the current fiscal year is revenue of ¥720 million (+24.4%).
Financial results — FY2026/12 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥401M | +59.8% |
| Operating profit | ¥-954M | -1005.0% |
| Net profit | n/a | n/a |
Next period forecast
Revenue
¥720M
+24.4%Op. profit
¥-2,028M
-2053.0%Figures in millions of yen
End of article